Vimarsana
Biggest News Aggregation in the World

Page 13 - Alpn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpn Today - Breaking & Trending Today

Colleges get creative to address nurse shortage - Vimarsana News

Colleges get creative to address nurse shortage

Amid a nationwide nursing shortage, schools across the country are looking for creative new ways to get students quickly into the health care job pipeline, as post-pandemic life begins to come into clearer view.

Source: 10news.com
North Country offers first LPN program in area - Vimarsana News

North Country offers first LPN program in area

A North Country program is aiming to quickly fill needed roles and give students career opportunities in the healthcare field.

Source: wmur.com
Alpine Immune Sciences, Inc. Forecasted to Earn Q1 2022 Earnings of ($0.27) Per Share (NASDAQ:ALPN) - Vimarsana News

Alpine Immune Sciences, Inc. Forecasted to Earn Q1 2022 Earnings of ($0.27) Per Share (NASDAQ:ALPN)

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Stock analysts at Wedbush issued their Q1 2022 earnings per share (EPS) estimates for shares of Alpine Immune Sciences in a research note issued to investors on Monday, March 21st. Wedbush analyst R. Driscoll anticipates that the biotechnology company will earn ($0.27) per share for the […]

Alpine Immune Sciences (NASDAQ:ALPN) Downgraded to Sell at Zacks Investment Research - Vimarsana News

Alpine Immune Sciences (NASDAQ:ALPN) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research cut shares of Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) from a hold rating to a sell rating in a report issued on Tuesday morning, Zacks.com reports. According to Zacks, “Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the […]

-$0.08 Earnings Per Share Expected for Alpine Immune Sciences, Inc. (NASDAQ:ALPN) This Quarter - Vimarsana News

-$0.08 Earnings Per Share Expected for Alpine Immune Sciences, Inc. (NASDAQ:ALPN) This Quarter

Wall Street brokerages expect Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) to post ($0.08) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have issued estimates for Alpine Immune Sciences’ earnings. Alpine Immune Sciences posted earnings per share of ($0.45) in the same quarter last year, which would indicate a positive […]